These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27165717)

  • 1. Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway.
    Cunha-Santos J; Duarte-Neves J; Carmona V; Guarente L; Pereira de Almeida L; Cavadas C
    Nat Commun; 2016 May; 7():11445. PubMed ID: 27165717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
    PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
    Vasconcelos-Ferreira A; Carmo-Silva S; Codêsso JM; Silva P; Martinez ARM; França MC; Nóbrega C; Pereira de Almeida L
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12763. PubMed ID: 34432315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.
    Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L
    Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
    Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
    J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
    Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
    Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective roles of carbonic anhydrase 8 in Machado-Joseph Disease.
    Hsieh M; Hsieh BY; Ma CY; Li YT; Liu CS; Lo CM
    J Neurosci Res; 2019 Oct; 97(10):1278-1297. PubMed ID: 31157458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.
    Vasconcelos-Ferreira A; Martins IM; Lobo D; Pereira D; Lopes MM; Faro R; Lopes SM; Verbeek D; Schmidt T; Nóbrega C; Pereira de Almeida L
    Mol Ther; 2022 Jan; 30(1):370-387. PubMed ID: 34298131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease.
    Duarte-Silva S; Silva-Fernandes A; Neves-Carvalho A; Soares-Cunha C; Teixeira-Castro A; Maciel P
    Neuroscience; 2016 Jan; 313():162-73. PubMed ID: 26601773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromised mitochondrial complex II in models of Machado-Joseph disease.
    Laço MN; Oliveira CR; Paulson HL; Rego AC
    Biochim Biophys Acta; 2012 Feb; 1822(2):139-49. PubMed ID: 22037589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease.
    Simões AT; Gonçalves N; Nobre RJ; Duarte CB; Pereira de Almeida L
    Hum Mol Genet; 2014 Sep; 23(18):4932-44. PubMed ID: 24817574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models.
    Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L
    Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
    Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
    J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.
    Costa Mdo C; Luna-Cancalon K; Fischer S; Ashraf NS; Ouyang M; Dharia RM; Martin-Fishman L; Yang Y; Shakkottai VG; Davidson BL; Rodríguez-Lebrón E; Paulson HL
    Mol Ther; 2013 Oct; 21(10):1898-908. PubMed ID: 23765441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Conceição M; Déglon N; de Almeida LP
    Cerebellum; 2013 Aug; 12(4):441-55. PubMed ID: 23242710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.
    Oliveira Miranda C; Marcelo A; Silva TP; Barata J; Vasconcelos-Ferreira A; Pereira D; Nóbrega C; Duarte S; Barros I; Alves J; Sereno J; Petrella LI; Castelhano J; Paiva VH; Rodrigues-Santos P; Alves V; Nunes-Correia I; Nobre RJ; Gomes C; Castelo-Branco M; Pereira de Almeida L
    Mol Ther; 2018 Sep; 26(9):2131-2151. PubMed ID: 30087083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice.
    Liu SW; Chang JC; Chuang SF; Liu KH; Cheng WL; Chang HJ; Chang HS; Lin TT; Hsieh CL; Lin WY; Hsieh M; Kuo SJ; Liu CS
    Cerebellum; 2019 Feb; 18(1):22-32. PubMed ID: 29725949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.